Clinical Trial Update: In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating THC-induced immune-genome changes at single-cell resolution in HIV-infected humans; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tetrahydrocannabinol (THC) (tetrahydrocannabinol)

Snippet

Sponsor: Yale University | Conditions: HIV Infections, Healthy | Phase 1 | Status: COMPLETED